Concepedia
Statistics
Publications
11
Citations
201
H-Index
Active since
1997
Affiliations
Bristol-Myers Squibb (United States)(Current)
Bristol-Myers Squibb (Sweden)
GlaxoSmithKline (United States)
Bristol-Myers Squibb (Belgium)
Bristol-Myers Squibb (Germany)
Susan Lubin is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, clinical pharmacology, and pharmacokinetics.
Publications per year
1997–2022
Single-Dose Pharmacokinetics of Milvexian in Participants with Mild or Moderate Hepatic Impairment Compared with Healthy Participants
Vidya Perera, Grigor Abelian, Danshi Li et al. · Clinical Pharmacokinetics · 2022 · 32 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +14
Effects of Itraconazole and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Milvexian, A Factor XIa Inhibitor
Vidya Perera, Zhaoqing Wang, Susan Lubin et al. · Cardiology and Therapy · 2022 · 22 citations · Full text
Medicine, Pharmacokinetics, Pharmacology +14
Single-Dose Pharmacokinetics of Milvexian in Participants with Normal Renal Function and Participants with Moderate or Severe Renal Impairment
Vidya Perera, Grigor Abelian, Danshi Li et al. · Clinical Pharmacokinetics · 2022 · 22 citations · Full text
Pharmacy, Pharmacokinetics, Pharmacology +16
Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants
Vidya Perera, Zhaoqing Wang, Susan Lubin et al. · Scientific Reports · 2022 · 20 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +6
Bioequivalence, Food Effect, and Steady‐State Assessment of Dapagliflozin/Metformin Extended‐release Fixed‐dose Combination Tablets Relative to Single‐component Dapagliflozin and Metformin Extended‐release Tablets in Healthy Subjects
Ming Chang, Xiaoni Liu, Dapeng Cui et al. · Clinical Therapeutics · 2015 · 19 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
1–5 of 11